Published Date: 11 Sep 2024
The c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an acceptable safety profile in patients of Asian race with c-Met protein-overexpressing, epidermal growth factor receptor ...
Read Full NewsAn investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.
A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.
The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.
Both drugs increase overall and progression-free survival.
1.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
2.
AI Unlocks Benefits of Prostate Cancer Treatment.
3.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
4.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
5.
Is Exercise an Effective Treatment for Prostate Cancer?
1.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
2.
Beyond the Battle: Navigating Life After Cancer
3.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
4.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
5.
A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation